FDA.reportPublic FDA data

Mepron 750 MG per 5 ML Oral Suspension

RxCUI
211947
RxNorm name
Mepron 750 MG per 5 ML Oral Suspension
Display name
Mepron 750 MG per 5 ML Oral Suspension
Full name
Mepron 750 MG per 5 ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MEPRONATOVAQUONEGlaxoSmithKline LLCb426b6bf-f07e-4580-97ae-dfca1ddf5b8f2026-03-20Warnings, Adverse reactionsExact identifier
rxcui: 211947

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b426b6bf-f07e-4580-97ae-dfca1ddf5b8fMEPRON 750 MG in 5 mL Oral Suspension [PSN] · atovaquone 150 MG/ML Oral Suspension [Mepron] [SBD] · Mepron 150 MG/ML Oral Suspension [SY] · Mepron 750 MG per 5 ML Oral Suspension [SY]427These highlights do not include all the information needed to use MEPRON oral suspension safely and effectively. See full prescribing information for MEPRON oral suspension. MEPRON (atovaquone oral suspension) Initial U.S. Approval: 199220260320